Our findings indicate that preoperative plasma levels of the cleaved uPAR forms could have a possible role in identification of patients at high risk of disease recurrence and cancer specific death which might allow a more individualised patient counselling and more focused use of perioperative therapy and/or a more individualised follow-up schedule. This evidence concerns the gene PLAUR and cancer.